by Konstantina Zafeiropoulou
Just one month before friends and families gather around the Christmas table, November is here to bring awareness around Clostridioides difficile infection, and the importance of microbiota-derived treatments. With this post, all of us in GMFH aim to highlight the importance of protecting ourselves and families and stopping the spread of this potentially deadly infection.
Research into microbial extracellular vesicles has progressed significantly over several decades. Following up on the 1989 breakthrough that bacterial extracellular vesicles contain genetic information, and the recent ISAPP definition on postbiotics, current research suggests bacterial extracellular vesicles derived from probiotic bacteria may be the postbiotics of the future with potential health benefits.
by Andreu Prados
Inflammation has been involved in the onset of chronic diseases. Probiotics emerge as a potential dietary tool for managing those conditions, partly through their role in immune system modulation and the anti-inflammatory response. Find out what is known about the anti-inflammatory effects of probiotics and their potential applications at the bedside.
by Andreu Prados
Bacteria and fungi in the human gut microbiota may contribute to the underlying mechanisms of IBS, which means the latter can be explored as a potential target for IBS. This article explores what is known about the role of the gut microbiome and yeast probiotics in irritable bowel syndrome.
by Andreu Prados
Correcting the altered gut microbiome is an important goal in Clostridioides difficile management, but the matter is not addressed by mainstream treatments with antibiotics. This article focuses on where fecal microbiota transplantation and investigational microbiota-based therapeutics stand for C. difficile infection (Part 3)
by Heather Galipeau
While celiac disease affects predominantly the small intestine, the contribution of the small intestinal microbiota has been largely understudied. New findings characterize the duodenal microbiota in patients with active celiac disease and explores its functional relevance.
by Giada De Palma
The third edition of IBS DAYS 2022 provided current advances and a look to future therapeutic approaches on the rapidly advancing field of irritable bowel syndrome. This article summarizes major highlights on diet and gut microbiome interactions of relevance for IBS.
by Andreu Prados
Patients usually ask for microbiome tests to manage gut-related issues, to find out what type of diet or food supplement fits best and to get information about the risk of developing chronic diseases. But what kind of information do microbiome tests provide and how reliable are their results for clinical practice?
by Andreu Prados
The gut-brain connection is largely shaped by the composition and function of gut-dwelling microbial communities. This review article addresses how the brain and gut communicate and considers potential psychobiotic therapies.
by Andreu Prados
The involvement of the gut microbiota in diverticulitis is gaining interest. This article explores what we know so far about the role of the gut microbiota in diverticulitis and discusses two recent clinical trials on the role of probiotics in managing acute uncomplicated diverticulitis.
